Overview

Clinical Study of Cang Ai Volatile Oil (CAVO) on Mild to Moderate Depression in Children and Adolescents

Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
A randomized controlled trial was conducted to observe the improvement of mild to moderate depressive symptoms in children and adolescents with the aromatic herbal compound Cang Ai Volatile Oil (CAVO) and to evaluate the effectiveness and safety of the clinical application of CAVO.
Phase:
Early Phase 1
Details
Lead Sponsor:
Chen Qian
Treatments:
Fluoxetine